老花眼矯正市場 - 調查報告(2025年)
市場調查報告書
商品編碼
1751656

老花眼矯正市場 - 調查報告(2025年)

2025 Presbyopia Correction Survey Report

出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

MarketScope 首版 "老花眼矯正市場 - 研究報告 (2025)" 提供了關於老花眼治療方法、採用計劃、平均價格以及塑造老花眼格局的新興技術的重要見解。從眼藥水到老花眼矯正人工水晶體,本報告提供了重要的研究數據,有助於您在眼部保健領域做出明智的決策。無論您是醫療保健提供者、研究人員還是投資者,本報告都能幫助您自信地應對不斷發展的老花眼市場。

目錄

本報告基於來自眼科專業人士的廣泛全球調查數據,深入分析了手術、藥物和光學老花眼矯正方案。

主要亮點包括:

  • 治療偏好:分析領先的老花眼管理策略(包括手術、藥物和光學方案)。
  • 人工水晶體市場動態:製造商平均價格趨勢、各品牌市場佔有率以及術後可調節和中期優化人工水晶體的未來採用計劃。
  • 屈光手術洞察:預測單視採用率、針對老花眼的LVC手術的單眼價格以及2025年的銷售量。
  • 藥物開發:預測Vuity和Qlosi等眼藥水的患者人口統計和處方趨勢,以及Lenz Therapeutics和Tenpoint Therapeutics即將推出的療法的認知度和採用趨勢。
  • 眼鏡市場概覽:視力矯正市場佔有率、品牌佔有率、更換計畫以及眼鏡、閱讀器和隱形眼鏡的購買頻率。
  • 決策推動因素:哪些因素推動或減緩了新眼藥水、隱形眼鏡和手術技術在現實世界中的應用?
簡介目錄

Market Scope's first-edition "2025 Presbyopia Survey Report" provides pivotal insights into treatment methods, adoption plans, average pricing, and emerging technologies shaping the presbyopia landscape. From drops to presbyopia-correcting IOLs, this report delivers survey data essential for informed decision-making in ophthalmic care. Whether you're a healthcare provider, researcher, or investor, leverage this report to navigate the evolving presbyopia market with confidence.

Contents:

Based on extensive global survey data from ophthalmic professionals, this report provides deep insights across surgical, pharmaceutical, and optical presbyopia correction options.

Key highlights include:

  • Treatment Preferences: Analysis of primary presbyopia management strategies, including surgical, pharmaceutical, and optical options.
  • IOL Market Dynamics: Trends in average manufacturer pricing, market share by brand, and future adoption plans for post-op adjustable and intermediate-optimized IOLs.
  • Refractive Surgery Insights: Monovision selection rates, per-eye fees for LVC procedures targeting presbyopia, and volume expectations for 2025.
  • Pharmaceutical Developments: Patient demographics and prescribing trends for drops like Vuity and Qlosi, plus awareness and adoption projections for upcoming therapies from Lenz Therapeutics and Tenpoint Therapeutics.
  • Optical Market Overview: Share of vision correction across glasses, readers, and contacts-plus brand market share, replacement schedules, and frequency of purchases.
  • Decision Drivers: What drives-or delays-adoption of new drops, lenses, and surgical technologies in real-world practice.